Literature DB >> 1384438

[Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens].

M Adriazola Semino1, J L Lozano Ortega, E García Cobo, E Tejeda Báñez, F Romero Rodríguez.   

Abstract

Forty-five patients diagnosed as having BPH and clinically diagnosed micturition disorders were entered in a therapeutic protocol. Twenty-five patients received Prazosin and the remaining 20 patients were treated with Serenoa Repens for a period of 12 weeks. The symptomatology was assessed by flowmetry and the patients were questioned as to the irritative symptoms. It can be concluded from the study that Prazosin is slightly more effective in controlling the irritative symptoms produced by BPH.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384438

Source DB:  PubMed          Journal:  Arch Esp Urol        ISSN: 0004-0614            Impact factor:   0.436


  7 in total

Review 1.  The role of plant-derived drugs and herbal medicines in healthcare.

Authors:  P A De Smet
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 2.  Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

Review 3.  Serenoa repens for benign prostatic hyperplasia.

Authors:  James Tacklind; Roderick Macdonald; Indy Rutks; Judith U Stanke; Timothy J Wilt
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 4.  Serenoa repens (saw palmetto): a systematic review of adverse events.

Authors:  Taofikat B Agbabiaka; Max H Pittler; Barbara Wider; Edzard Ernst
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 5.  Pharmacological effects of saw palmetto extract in the lower urinary tract.

Authors:  Mayumi Suzuki; Yoshihiko Ito; Tomomi Fujino; Masayuki Abe; Keizo Umegaki; Satomi Onoue; Hiroshi Noguchi; Shizuo Yamada
Journal:  Acta Pharmacol Sin       Date:  2009-03       Impact factor: 6.150

Review 6.  Serenoa repens for benign prostatic hyperplasia.

Authors:  James Tacklind; Roderick MacDonald; Indy Rutks; Timothy J Wilt
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

Review 7.  Alpha-blockers: an effective treatment for prostatitis?

Authors:  D Caropreso; T D Moon
Journal:  Curr Urol Rep       Date:  2000-08       Impact factor: 3.092

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.